No problem, reverend, I never thought you were being preachy. I was the one who pulled a bit of Proverbs 27:17 into my last post.
I fully agree that having a buyout as the exit strategy (unless the ink is already dry on the agreement and it's cleared all hurdles with the courts) is not a good strategy. I even have a percentage number of shares that I will immediately sell should a buyout be announced just in case it drags or fails. Certainly, we can include a buyout assumption in establishing a target price, albeit, I think it should be a small factor. The reason being that in this sector of small to medium start-up biotechs with the goods have a pattern of going that route.
As always, thanks for sharing.
News 
Market Data 
Discover 
